Published December, 2010
By R.Van Furth and R. van Furth
Publisher: Springer
Rating:
Availability: Available

Mononuclear phagocytes, which include macrophages, monocytes and their precursor cells, are the most important cells in the host defence against micro-organisms and tumor cells. in 1975 Mononuclear Phagocytes in Immunity, Infections and Pathology; and in 1985 Mononuclear Phagocytes -- Characteristics, Physiology and Function.

---

Published December, 2010
By R. Fuller, G. Perdigon and Gabriela Perdigón
Publisher: Springer
Rating:
Availability: Available

It seemed that the immunogenic potential of probiotics merited a book of its own with experts from all over the world covering the general effect of the gut microflora on immunity as well as the particular response that pro biotic microorganisms generate.

---

Published December, 2010
By Guy Touchard, Pierre Aucouturier, Olivier Hermine, Pierre Ronco, G. Touchard, Dr Aucouturier and O. Hermine
Publisher: Springer
Rating:
Availability: Available

---

Published December, 2010
By Jurgen A.. Richt, Bernhard Dietzschold, B. Dietzschold and J.A. Richt
Publisher: Springer (Springer-Verlag Berlin and Heidelberg GmbH & Co. K)
Series: Current Topics in Microbiology and Immunology
Rating:
Availability: Available

In spite of the protection of the CNS there are situations where immune responses occur due to different disease processes. While antigen-specific cells of the adaptive immune response are not normally functional in the CNS tissue, CNS resident cells respond to infection or insult.

---

Published December, 2010
By Christian Tschudi and Edward J. Pearce
Publisher: Springer (Springer-Verlag New York Inc.)
Rating:
Availability: Available

Biology of Parasitism is based on the Biology of Parasitism Course at the Marine Biological Laboratory in Woods Hole, Massachusetts. As in the Course, the experimental part is complemented by a number of review-like chapters solicited from the large number of speakers who lecture during the Course.

---

Published December, 2010
By Jennifer J. Shin, Christopher J. Hartnick, Gregory Randolph, Jennifer Shin and Christopher Hartnick
Publisher: Springer (Springer-Verlag New York Inc.)
Rating:
Availability: Available

Each clinical problem is presented with a "color key," letting the physician know the level of evidence available: green (high-level evidence), yellow (low-moderate levels of evidence), or red (major disagreement or only minimal low-level evidence).

---

Published December, 2010
By Dominik Wodarz
Publisher: Springer (Springer-Verlag New York Inc.)
Series: Interdisciplinary Applied Mathematics
Rating:
Availability: Available

This book reviews how mathematical and computational approaches can be useful to help us understand how killer T-cell responses work to fight viral infections.

---

Published December, 2010
By T.M. Koehler and Theresa Koehler
Publisher: Springer (Springer-Verlag Berlin and Heidelberg GmbH & Co. K)
Series: Current Topics in Microbiology and Immunology
Rating:
Availability: Available

Bacillus anthracis causes anthrax in all mammals, including humans. The continuing worldwide incidence of anthrax in animal populations, the risk of human infection associated with animal outbreaks, and the threat of use of B.

---

Published November, 2010
By Shyam Mohapatra and Gary Hellermann
Publisher: Elsevier (W B Saunders Co Ltd)
Series: The Clinics: Internal Medicine
Rating:
Availability: Available

Covers such topics as: virus-induced airway injury and asthma inception; pediatric infectious diseases and asthma; rhinoviruses and inception or exacerbation of asthma; and, respiratory syncytial virus infections in the adult asthmatic-role of viral subversion and host susceptibility in RSV infection.

---

Published November, 2010
By W.B. Harrison and B.A.C. Dijkmans
Publisher: Springer (Springer-Verlag Berlin and Heidelberg GmbH & Co. K)
Rating:
Availability: Available

Despite the advance of instituting monotherapy with a single optimised disease-modifying anti-rheumatic drug (DMARD) - with methotrexate as prototype agent in RA - adequate disease re mission is not often achieved, and adverse events may well prevent the use of higher dosages of the single agent in question.

---